Trademark: 90172385
Status Date
Wednesday, March 13, 2024
Filing Date
Thursday, September 10, 2020
Published for Opposition
Tuesday, January 18, 2022
5 companion diagnostic agents for medical use, namely, for testing of bodily fluids for use in predicting the risk of disease, namely, cancer; diagnostic kits comprised of diagnostic reagents and assay components for medical use; diagnostic kits comprised of diagnostic reagents and assay components for medical use, namely, for testing of bodily fluids for use in predicting the risk of disease, namely, cancer
1 diagnostic reagents and assay components for clinical and medical laboratory use; assay components for clinical and medical laboratory use, namely, for clinical research and testing, genetic research and testing, and testing of biological samples; kits comprised of diagnostic reagents and assay components for clinical and medical laboratory use, namely, for clinical research and testing, genetic research and testing, and testing of biological samples
44 Medical diagnostic testing, namely, companion diagnostic tests of therapeutic drugs in the nature of testing for medical diagnostic or treatment purposes in the field of oncology; medical diagnostic testing, monitoring, and reporting services pertaining to the monitoring, diagnosis and treatment of disease; medical diagnostic testing, monitoring and reporting services
42 medical diagnostic testing, namely companion diagnostic tests of therapeutic drugs in the nature of clinical trials for others
LAG ASSURE; LYMPHOCYTE ACTIVATION GENE ASSURE
Mar 15, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2024
Sou Extension 4 Granted
Mar 13, 2024
Sou Extension 4 Filed
Mar 13, 2024
Sou Teas Extension Received
Sep 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2023
Sou Extension 3 Granted
Sep 13, 2023
Sou Extension 3 Filed
Sep 13, 2023
Sou Teas Extension Received
Mar 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2023
Sou Extension 2 Granted
Mar 15, 2023
Sou Extension 2 Filed
Mar 15, 2023
Sou Teas Extension Received
Jan 20, 2023
Assigned To Examiner
Sep 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 14, 2022
Sou Extension 1 Granted
Sep 14, 2022
Sou Extension 1 Filed
Sep 14, 2022
Sou Teas Extension Received
Mar 15, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 18, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 18, 2022
Published For Opposition
Dec 29, 2021
Notification Of Notice Of Publication E-Mailed
Dec 10, 2021
Approved For Pub - Principal Register
Nov 17, 2021
Teas/Email Correspondence Entered
Nov 16, 2021
Correspondence Received In Law Office
Nov 16, 2021
Teas Response To Office Action Received
May 22, 2021
Notification Of Non-Final Action E-Mailed
May 22, 2021
Non-Final Action E-Mailed
May 22, 2021
Non-Final Action Written
May 13, 2021
Teas/Email Correspondence Entered
May 13, 2021
Correspondence Received In Law Office
May 13, 2021
Teas Response To Office Action Received
Nov 16, 2020
Notification Of Non-Final Action E-Mailed
Nov 16, 2020
Non-Final Action E-Mailed
Nov 16, 2020
Non-Final Action Written
Nov 6, 2020
Assigned To Examiner
Oct 19, 2020
New Application Office Supplied Data Entered
Sep 14, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
